Yaohai Bio-Pharma, a contract research, development and manufacturing organization (CRDMO) that specializes in microbial expression systems, announced today that it will exhibit at BioProcess International
Yaohai Bio-Pharma has once again been recognized as a leading innovator in the global biopharmaceutical industry. During the 2026 Future Healthcare 100 Conference held on
Yaohai Bio-Pharma is a leading CRDMO specializing in microbial expression systems. We offer end-to-end purification process development, starting from primary purification and moving all the
